US Patent 11866742 Fusion proteins comprising enzyme replacement therapy enzymes
Patent 11866742 was granted and assigned to Denali Therapeutics on January, 2024 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
November 23, 2020
0
Date of Patent
January 9, 2024
0
Patent Applicant
Patent Application Number
17102138
0
Patent Citations
•••
Patent Inventor Names
Cathal S. Mahon
0
Mihalis S. Kariolis
0
Julie Ullman
0
Ankita Srivastava
0
Anastasia Henry
0
Adam P. Silverman
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11866742 Fusion proteins comprising enzyme replacement therapy enzymes
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.